Kraig Biocraft Labs Stock Today

KBLB Stock  USD 0.14  0.01  6.67%   


10 of 100


Odds Of Distress

Less than 39

Below Average
Kraig Biocraft is trading at 0.14 as of the 15th of June 2024, a -6.67 percent down since the beginning of the trading day. The stock's open price was 0.15. Kraig Biocraft has about a 39 percent probability of financial distress in the next few years of operation but had a somewhat ok performance during the last 90 days. Equity ratings for Kraig Biocraft Labs are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of June 2022 and ending today, the 15th of June 2024. Click here to learn more.
Kraig Biocraft Laboratories, Inc. engages in developing protein-based fibers using recombinant DNA technology for commercial applications in the technical textile and specialty fiber industries in the United States. The company was incorporated in 2006 and is headquartered in Ann Arbor, Michigan. The company has 1.02 B outstanding shares. More on Kraig Biocraft Labs

Moving together with Kraig OTC Stock

  0.61CHKEW Chesapeake EnergyPairCorr

Moving against Kraig OTC Stock

  0.8BKRKF PT Bank RakyatPairCorr
  0.73PPERY Bank Mandiri PerseroPairCorr
  0.71PCTTW PureCycle TechnologiesPairCorr
  0.68PPERF Bank Mandiri PerseroPairCorr
  0.65PTAIF PT Astra InternationalPairCorr
  0.65PBCRY Bank Central AsiaPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Kraig OTC Stock Highlights

ChairmanKim Thompson
Business ConcentrationMaterials, Chemicals, Specialty Chemicals, Basic Materials (View all Sectors)
Kraig Biocraft Labs [KBLB] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with a current market capitalization of 38.03 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Kraig Biocraft's market, we take the total number of its shares issued and multiply it by Kraig Biocraft's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Kraig Biocraft Labs conducts business under Chemicals sector and is part of Materials industry. The entity has 1.02 B outstanding shares. Kraig Biocraft Labs currently holds about 4.82 M in cash with (1.8 M) of positive cash flow from operations.
Check Kraig Biocraft Probability Of Bankruptcy
Ownership Allocation
Kraig Biocraft Labs maintains a total of 1.02 Billion outstanding shares. Kraig Biocraft Labs holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Kraig Ownership Details

Kraig Biocraft Labs Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Kraig Biocraft market risk premium is the additional return an investor will receive from holding Kraig Biocraft long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Kraig Biocraft. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Kraig Biocraft's alpha and beta are two of the key measurements used to evaluate Kraig Biocraft's performance over the market, the standard measures of volatility play an important role as well.

Kraig Stock Against Markets

Picking the right benchmark for Kraig Biocraft otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Kraig Biocraft otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Kraig Biocraft is critical whether you are bullish or bearish towards Kraig Biocraft Labs at a given time. Please also check how Kraig Biocraft's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Kraig Biocraft without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Funds Screener Now


Funds Screener

Find actively-traded funds from around the world traded on over 30 global exchanges
All  Next Launch Module

Other Information on Investing in Kraig OTC Stock

Kraig Biocraft financial ratios help investors to determine whether Kraig OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kraig with respect to the benefits of owning Kraig Biocraft security.